hydroxychloroquinegemcitabinenivolumabipilimumabnab-paclitaxelhydroxychloroquine-relatedmPDACcytotoxic therapychemoimmunotherapy combinationsmetastatic pancreatic ductal adenocarcinoma (mPDAC)+2 more
…umab (360 mg intravenously every 3 weeks) and cohort B received hydroxychloroquine (600 mg orally two times a day). The primary endpoint was safet…